Posted on April 29, 2008 by TKtraveler
The World Congress kicked off on Sunday in Chicago and sustainability was on everyone’s mind.
John Heissenbuttel of Heissenbuttel Natural Resource Consulting announced an initiative to make sure that advanced biofuels are produced in a sustainable manner. The groups involved will set voluntary standards to ensure cellulosic biomass – dedicated fuel crops, crop residues, purpose-grown wood, [...]
Filed under: World Congress | Leave a Comment »
Posted on April 24, 2008 by ecreese
Putting a value on how much an early-stage biotech company is worth is no easy task. Raising money for an early-stage biotech is even harder. But the good news is that last year was a record year for financing in the industry, with a 66 percent increase in VC funding over 2006, according a recently [...]
Filed under: National Venture Conference | Leave a Comment »
Posted on April 23, 2008 by ecreese
Attendees awoke to the news this morning about GlaxoSmithKline’s announcement that it will pay millions — $720 million to be exact — for Sirtris Pharmaceuticals. This is the stuff biotech CEOs dream about. And it was the buzz at many breakfast tables at this morning’s workshop, “Antibiotics: Bad Bugs – Few Drugs.”
The BNVC meeting, of [...]
Filed under: National Venture Conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, National Venture Conference, venture funding | Leave a Comment »
Posted on April 22, 2008 by ecreese
More than 60 company presentations are scheduled to take place between today and tomorrow. Whether you sat in on Optherion, Colby Pharmaceutical, or another presentation, chances are the session was jammed pack. Each presenter was allotted 15 minutes to make the case for why his or her company is the company to invest in. – [...]
Filed under: National Venture Conference | Leave a Comment »
Posted on April 22, 2008 by ecreese
While the economy may not be as robust as it has in recent years, there certainly was no sign of that at today’s Opening Luncheon. Jim Greenwood, our President & CEO welcomed attendees to the inaugural BIO National Venture Conference and cited these impressive stats:
140 top-level (VP and higher) venture capitalists – including 4 international investors – [...]
Filed under: National Venture Conference, Uncategorized | Tagged: BIO, biotechnology, Biotechnology Industry Organization, National Venture Conference, nvc, venture funding | Leave a Comment »
Posted on April 22, 2008 by ecreese
The marathon may be over, but that doesn’t mean there isn’t plenty more activity going on here in Boston. We’re here in Cambridge, one of biotechnology’s “hot-spots” for the inaugural BIO National Venture Conference meeting up with some of the newest early stage and seed stage companies seeking venture funding. Stay tuned for more as the [...]
Filed under: National Venture Conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, bnvc, National Venture Conference, venture funding | Leave a Comment »
Posted on April 4, 2008 by nicoleatbio
Here at BIO, we are rethinking our online strategy and we can’t do it without you. Help us provide you with the best online information, tools and resources possible and…..
Take our survey!
Filed under: Uncategorized | Leave a Comment »
Posted on April 4, 2008 by TKtraveler
The Scientist, our trade publication partner for the daily newsletter at the convention, has extended their editorial submission deadline to April 30th. To submit newsworthy content, go to www.the-scientist.com/bio/index/ . Submit something today!
Filed under: Convention | Leave a Comment »
Posted on April 3, 2008 by TKtraveler
The 2008 BIO International Convention will be truly global, with international case studies, global health breakout sessions and significant international attendance.
Since 2006, international attendance has grown by more than 24% and now makes up more than 30% of the audience. In 2008, more growth is expected from Asia and Latin America.
Global health breakout sessions [...]
Filed under: Convention | Leave a Comment »